Abbott India Ltd (ABBOTINDIA) Q1 FY27 Results Analysis: PAT Jumps 17%, Revenue Lags Industry

Abbott India Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 1,813.68 Cr (+4.33% YoY) and PAT growth of +17.13% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quarter Snapshot

Revenue growth decelerated to 4.33% YoY, lagging industry growth, but PAT grew 17% due to operating leverage and cost controls. EBITDA margin expanded 314bps YoY, partly from a temporary inventory-FX benefit expected to reverse. Weak top-line performance relative to peers is a concern.

Key Investment Insights

Key Positives

• Revenue grew 4.33% YoY to Rs.1,813.68 Cr.
• PAT grew 17.13% YoY to Rs.428.52 Cr.
• EBITDA margin expanded 314 bps YoY to 32.96%.
• Employee cost growth slowed to 4.30% YoY from 13.8% in FY26.
• Inventory build reduced to Rs.31.10 Cr from Rs.72.85 Cr YoY.

Risk Factors

• Revenue growth decelerated to 4.33% YoY, below FY26's 8.1% and below IPM estimate of ~11.3%, indicating possible market share loss.
• EBITDA margin expansion of 314 bps was partly driven by temporary inventory-FX benefit; purchases ratio expected to revert to 48-50% as old stock is replaced.